Segment Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Segment Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-1,995	Closed	-$225K	–	160
2015 Q4	$225K	Sell	1,995 -45	-2%	-$4.88K	0.09%	138
2015 Q3	$206K	Sell	2,040 -480	-19%	-$57.6K	0.08%	154
2015 Q2	$310K	Sell	2,520 -111	-4%	-$13.3K	0.11%	130
2015 Q1	$301K	Hold	2,631	–	–	0.1%	133
2014 Q4	$266K	Hold	2,631	–	–	0.1%	128
2014 Q3	$240K	Sell	2,631 -210	-7%	-$18.4K	0.09%	151
2014 Q2	$243K	Sell	2,841 -11,784	-81%	-$928K	0.09%	152
2014 Q1	$1.15M	Sell	14,625 -7,308	-33%	-$609K	0.54%	64
2013 Q4	$1.66M	Sell	21,933 -21,528	-50%	-$1.53M	0.82%	41
2013 Q3	$3.04M	Buy	43,461 +1,569	+4%	+$103K	1.65%	12
2013 Q2	$2.43M	Buy	+41,892	New	+$2.42M	1.45%	11

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Segment Wealth Management's IBB Position: Q1 2016 in Review

Segment Wealth Management sold out of iShares Biotechnology ETF (IBB) in Q1 2016, closing a stake of 1,995 shares — an estimated $225K sold.

Segment Wealth Management first reported a position in IBB in Q2 2013 and held it in 11 quarters. The position peaked at $3.04M in Q3 2013. 415 funds tracked by Wall St. Rank hold IBB as of Q1 2016.

Segment Wealth Management reported no remaining iShares Biotechnology ETF position as of Q1 2016 after selling out during the quarter.
Segment Wealth Management sold 1,995 iShares Biotechnology ETF shares in Q1 2016, an estimated $225K.
Segment Wealth Management first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 11 quarters.
Segment Wealth Management's iShares Biotechnology ETF position peaked at $3.04M in Q3 2013.
415 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2016.

Based on Segment Wealth Management's 13F filing for Q1 2016, filed 11 May 2016.